Published in Proc Natl Acad Sci U S A on June 23, 1998
Retracted XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A (2009) 6.72
Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol (2003) 4.47
Structural organization of authentic, mature HIV-1 virions and cores. EMBO J (2003) 4.32
The structural biology of HIV assembly. Curr Opin Struct Biol (2008) 3.71
RNA is a structural element in retrovirus particles. Proc Natl Acad Sci U S A (2001) 3.45
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol (1999) 3.34
Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography. Proc Natl Acad Sci U S A (2005) 3.17
Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J Virol (2000) 2.80
Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J Virol (2004) 2.37
Organization of immature human immunodeficiency virus type 1. J Virol (2001) 2.34
Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J (1999) 2.33
Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy. J Virol (1999) 2.15
Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J (2000) 2.08
Characterization of Rous sarcoma virus Gag particles assembled in vitro. J Virol (2001) 1.85
Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag). J Virol (2000) 1.76
Visualization of a missing link in retrovirus capsid assembly. Nature (2009) 1.75
Structure of the immature retroviral capsid at 8 Å resolution by cryo-electron microscopy. Nature (2012) 1.70
Nucleic acid-independent retrovirus assembly can be driven by dimerization. J Virol (2002) 1.66
Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J Mol Biol (2006) 1.65
A stiffness switch in human immunodeficiency virus. Biophys J (2006) 1.64
Conformation of the HIV-1 Gag protein in solution. J Mol Biol (2006) 1.59
Membrane association induces a conformational change in the Ebola virus matrix protein. EMBO J (2000) 1.59
Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly. EMBO J (2003) 1.58
Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions. J Virol (2001) 1.55
Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro. J Virol (2002) 1.55
Novel approaches to inhibiting HIV-1 replication. Antiviral Res (2009) 1.48
Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J Virol (2005) 1.40
Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli. J Virol (2000) 1.40
Mechanical properties of murine leukemia virus particles: effect of maturation. Biophys J (2006) 1.35
Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy. J Virol (2006) 1.34
Atomic force microscopy investigation of human immunodeficiency virus (HIV) and HIV-infected lymphocytes. J Virol (2003) 1.32
Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain. J Virol (2001) 1.24
Viral capsids: mechanical characteristics, genome packaging and delivery mechanisms. Cell Mol Life Sci (2007) 1.24
RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis. J Mol Biol (2007) 1.19
On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch? J Virol (2011) 1.17
Structural maturation of the transmissible gastroenteritis coronavirus. J Virol (1999) 1.13
Irregular and Semi-Regular Polyhedral Models for Rous Sarcoma Virus Cores. Comput Math Methods Med (2008) 1.12
Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein. J Virol (2007) 1.12
Effects of blocking individual maturation cleavages in murine leukemia virus gag. J Virol (2004) 1.12
Fluorescence fluctuation spectroscopy on viral-like particles reveals variable gag stoichiometry. Biophys J (2009) 1.10
Conserved and variable features of Gag structure and arrangement in immature retrovirus particles. J Virol (2010) 1.09
Secondary structure of the mature ex virio Moloney murine leukemia virus genomic RNA dimerization domain. J Virol (2009) 1.09
HIV type 1 Gag as a target for antiviral therapy. AIDS Res Hum Retroviruses (2011) 1.08
Assembly of retrovirus capsid-nucleocapsid proteins in the presence of membranes or RNA. J Virol (2000) 1.08
Analysis of Mason-Pfizer monkey virus Gag particles by scanning transmission electron microscopy. J Virol (2001) 1.07
Key Golgi factors for structural and functional maturation of bunyamwera virus. J Virol (2005) 1.06
The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteases. J Virol (2003) 1.06
Ty3 capsid mutations reveal early and late functions of the amino-terminal domain. J Virol (2007) 1.03
Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc Natl Acad Sci U S A (2009) 1.02
Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli. J Virol (2002) 1.02
Reversible binding of recombinant human immunodeficiency virus type 1 gag protein to nucleic acids in virus-like particle assembly in vitro. J Virol (2002) 1.01
Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly. J Virol (2008) 1.00
Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology. J Virol (2007) 1.00
Design of in vitro symmetric complexes and analysis by hybrid methods reveal mechanisms of HIV capsid assembly. J Mol Biol (2011) 0.97
Cryoelectron microscopy of mouse mammary tumor virus. J Virol (2004) 0.96
Effects of Gag mutation and processing on retroviral dimeric RNA maturation. J Virol (2006) 0.94
Important role for the CA-NC spacer region in the assembly of bovine immunodeficiency virus Gag protein. J Virol (2004) 0.93
Investigation by atomic force microscopy of the structure of Ty3 retrotransposon particles. J Virol (2005) 0.92
Nucleic acid chaperone activity of retroviral Gag proteins. RNA Biol (2010) 0.92
Viruses and the physics of soft condensed matter. Proc Natl Acad Sci U S A (2004) 0.91
Characterization of a myristoylated, monomeric HIV Gag protein. Virology (2009) 0.89
New insights into retroviral Gag-Gag and Gag-membrane interactions. Front Microbiol (2014) 0.89
How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle. Virus Res (2014) 0.88
Proton-driven assembly of the Rous Sarcoma virus capsid protein results in the formation of icosahedral particles. J Biol Chem (2010) 0.88
PR domain of rous sarcoma virus Gag causes an assembly/budding defect in insect cells. J Virol (2001) 0.87
Murine leukemia viruses: objects and organisms. Adv Virol (2011) 0.87
Directly monitoring individual retrovirus budding events using atomic force microscopy. Biophys J (2007) 0.86
Cooperative role of the MHR and the CA dimerization helix in the maturation of the functional retrovirus capsid. Virology (2008) 0.86
Atomic force microscopy investigation of isolated virions of murine leukemia virus. J Virol (2005) 0.85
NMR relaxation studies of an RNA-binding segment of the rous sarcoma virus gag polyprotein in free and bound states: a model for autoinhibition of assembly. Biochemistry (2010) 0.85
Atomic force microscopy and electron microscopy analysis of retrovirus Gag proteins assembled in vitro on lipid bilayers. Biophys J (2000) 0.84
In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV. J Virol (2011) 0.83
The p12 domain is unstructured in a murine leukemia virus p12-CA(N) Gag construct. PLoS One (2008) 0.83
Phylogeny-directed search for murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome and prostate cancer. Adv Virol (2011) 0.83
Solution properties of murine leukemia virus gag protein: differences from HIV-1 gag. J Virol (2011) 0.82
A small loop in the capsid protein of Moloney murine leukemia virus controls assembly of spherical cores. J Virol (2006) 0.82
Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions. J Virol (2012) 0.81
Genetic Studies of the beta-hairpin loop of Rous sarcoma virus capsid protein. J Virol (2006) 0.81
An immature retroviral RNA genome resembles a kinetically trapped intermediate state. J Virol (2014) 0.80
Multimerization of the p12 domain is necessary for Mason-Pfizer monkey virus Gag assembly in vitro. Virology (2007) 0.80
Role of Mason-Pfizer monkey virus CA-NC spacer peptide-like domain in assembly of immature particles. J Virol (2014) 0.80
Distinct Morphology of Human T-Cell Leukemia Virus Type 1-Like Particles. Viruses (2016) 0.79
Morphology and ultrastructure of retrovirus particles. AIMS Biophys (2015) 0.79
The N-terminus of murine leukaemia virus p12 protein is required for mature core stability. PLoS Pathog (2014) 0.78
Distinct Particle Morphologies Revealed through Comparative Parallel Analyses of Retrovirus-Like Particles. J Virol (2016) 0.78
Maturation of the Gag core decreases the stability of retroviral lipid membranes. Virology (2012) 0.77
Native structure of a retroviral envelope protein and its conformational change upon interaction with the target cell. J Struct Biol (2016) 0.75
Oligomeric viral proteins: small in size, large in presence. Crit Rev Biochem Mol Biol (2016) 0.75
Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed through Characterization of a Chronically Infected Cell Line. J Virol (2017) 0.75
Perturbation of Human T-Cell Leukemia Virus Type 1 Particle Morphology by Differential Gag Co-Packaging. Viruses (2017) 0.75
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
Nucleotide sequence of Moloney murine leukaemia virus. Nature (1981) 24.82
Physical principles in the construction of regular viruses. Cold Spring Harb Symp Quant Biol (1962) 17.87
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Core structure of gp41 from the HIV envelope glycoprotein. Cell (1997) 16.18
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science (1992) 14.70
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47
Form, function, and use of retroviral gag proteins. AIDS (1991) 9.24
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology (1987) 7.92
A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol (1995) 7.30
Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci U S A (1986) 7.02
Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell (1996) 6.74
Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science (1994) 6.69
Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc Natl Acad Sci U S A (1988) 6.44
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science (1997) 6.10
The T=4 envelope of Sindbis virus is organized by interactions with a complementary T=3 capsid. Cell (1987) 5.99
High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell (1978) 5.72
Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J Virol (1989) 5.47
Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science (1996) 5.44
Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol (1995) 5.21
Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification. Proc Natl Acad Sci U S A (1983) 5.12
RNA packaging. Curr Top Microbiol Immunol (1996) 4.88
Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J Virol (1986) 4.85
Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci U S A (1996) 4.83
Procedures for three-dimensional reconstruction of spherical viruses by Fourier synthesis from electron micrographs. Philos Trans R Soc Lond B Biol Sci (1971) 4.75
Assembly and morphology of HIV: potential effect of structure on viral function. AIDS (1991) 4.73
Retrovirus envelope domain at 1.7 angstrom resolution. Nat Struct Biol (1996) 4.49
Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src. J Virol (1991) 4.25
Crystal structure of dimeric HIV-1 capsid protein. Nat Struct Biol (1996) 3.93
Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol (1994) 3.85
Maturation of dimeric viral RNA of Moloney murine leukemia virus. J Virol (1993) 3.78
A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell (1990) 3.70
Interactions of retroviral structural proteins with single-stranded nucleic acids. J Biol Chem (1987) 3.62
Proteins of helper-dependent RSV. Virology (1971) 3.62
Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle. Curr Biol (1997) 3.59
Assembly of type C oncornaviruses: a model. Science (1978) 3.53
Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J Mol Biol (1997) 3.50
In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur J Biochem (1997) 3.38
Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J Virol (1974) 3.37
Properties of a ribonucleoprotein particle isolated from Nonidet P-40-treated Rous sarcoma virus. J Virol (1972) 3.25
Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science (1997) 3.13
Reconstruction of the three-dimensional structure of simian virus 40 and visualization of the chromatin core. Proc Natl Acad Sci U S A (1988) 3.09
Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events. J Virol (1989) 2.90
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1. Protein Sci (1992) 2.79
Harmonic analysis of electron microscope images with rotational symmetry. J Mol Biol (1971) 2.55
Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching. Virology (1972) 2.26
Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand ("immature") to a collapsed ("mature") form of the virus core. Proc Natl Acad Sci U S A (1977) 2.22
Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J Virol (1994) 2.21
Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR. EMBO J (1992) 2.21
Selective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA. J Virol (1979) 2.04
Quasi-equivalent viruses: a paradigm for protein assemblies. J Mol Biol (1997) 2.01
Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus. Virology (1994) 1.95
Three-dimensional structure of the rotavirus haemagglutinin VP4 by cryo-electron microscopy and difference map analysis. EMBO J (1994) 1.90
Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1. J Gen Virol (1994) 1.65
Dynamic interactions of the Gag polyprotein. Curr Top Microbiol Immunol (1996) 1.53
Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR. J Mol Biol (1994) 1.49
Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor. Arch Virol (1991) 1.49
Structural analysis of membrane-bound retrovirus capsid proteins. EMBO J (1997) 1.48
Structure of viruses of the papilloma-polyoma type. IV. Analysis of tilting experiments in the electron microscope. J Mol Biol (1968) 1.46
Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding. J Biol Chem (1996) 1.43
Comparative morphology and structural classification of retroviruses. Curr Top Microbiol Immunol (1996) 1.38
Further evidence of icosahedral symmetry in human and simian immunodeficiency virus. AIDS Res Hum Retroviruses (1993) 1.24
X-ray structures of retroviral proteases and their inhibitor-bound complexes. Methods Enzymol (1994) 0.79
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Molecular portraits of human breast tumours. Nature (2000) 94.14
Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 88.48
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell (1998) 62.20
Exploring the metabolic and genetic control of gene expression on a genomic scale. Science (1997) 60.15
The transcriptional program of sporulation in budding yeast. Science (1998) 37.23
Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell (2000) 36.09
Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet (2000) 24.22
Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A (1996) 24.18
A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res (1996) 23.16
Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature (2001) 21.55
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci U S A (2000) 18.42
Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A (2001) 17.36
Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73
Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet (1999) 14.96
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A (1999) 14.16
A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31
Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat Genet (2001) 13.05
DNA arrays for analysis of gene expression. Methods Enzymol (1999) 12.50
Correct integration of retroviral DNA in vitro. Cell (1987) 10.73
Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med (1998) 9.72
A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev (1989) 8.80
Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. Am J Hum Genet (1993) 8.05
The Stanford Microarray Database. Nucleic Acids Res (2001) 7.77
Integration of murine leukemia virus DNA depends on mitosis. EMBO J (1993) 7.62
Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci U S A (1986) 7.02
A structural change in the kinesin motor protein that drives motility. Nature (1999) 6.92
Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc Natl Acad Sci U S A (1988) 6.44
Genomic expression responses to DNA-damaging agents and the regulatory role of the yeast ATR homolog Mec1p. Mol Biol Cell (2001) 6.39
Energy coupling in DNA gyrase and the mechanism of action of novobiocin. Proc Natl Acad Sci U S A (1978) 6.33
Comparative gene expression profiles following UV exposure in wild-type and SOS-deficient Escherichia coli. Genetics (2001) 6.29
Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays. Proc Natl Acad Sci U S A (2001) 6.07
Yeast microarrays for genome wide parallel genetic and gene expression analysis. Proc Natl Acad Sci U S A (1997) 5.59
Global mapping of meiotic recombination hotspots and coldspots in the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2000) 5.57
Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol (1990) 5.45
Systematic changes in gene expression patterns following adaptive evolution in yeast. Proc Natl Acad Sci U S A (1999) 5.45
Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science (1992) 4.97
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83
Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. Virology (1985) 4.65
Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2000) 4.54
Two yeast forkhead genes regulate the cell cycle and pseudohyphal growth. Nature (2000) 4.52
Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci U S A (1999) 4.33
Genome-wide characterization of the Zap1p zinc-responsive regulon in yeast. Proc Natl Acad Sci U S A (2000) 4.30
A 35-A movement of smooth muscle myosin on ADP release. Nature (1995) 4.28
New components of a system for phosphate accumulation and polyphosphate metabolism in Saccharomyces cerevisiae revealed by genomic expression analysis. Mol Biol Cell (2000) 4.17
Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc Natl Acad Sci U S A (1999) 4.12
Information access. Building a "GenBank" of the published literature. Science (2001) 3.95
Effects of local cell concentrations upon the growth of chick embryo cells in tissue culture. Exp Cell Res (1968) 3.94
Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells. Virology (1982) 3.86
Coordinate regulation of yeast ribosomal protein genes is associated with targeted recruitment of Esa1 histone acetylase. Mol Cell (2000) 3.80
Maturation of dimeric viral RNA of Moloney murine leukemia virus. J Virol (1993) 3.78
Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses. J Virol (1990) 3.77
Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol (2001) 3.58
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J Virol (1994) 3.54
RNA is a structural element in retrovirus particles. Proc Natl Acad Sci U S A (2001) 3.45
Genomic mismatch scanning: a new approach to genetic linkage mapping. Nat Genet (1993) 3.35
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol (1999) 3.34
A sign inversion mechanism for enzymatic supercoiling of DNA. Science (1979) 3.31
The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J Virol (1993) 3.29
Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J Virol (1993) 3.28
Widespread cytoplasmic mRNA transport in yeast: identification of 22 bud-localized transcripts using DNA microarray analysis. Proc Natl Acad Sci U S A (2003) 3.16
Regulation of CSF1 promoter by the SWI/SNF-like BAF complex. Cell (2001) 3.10
Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays. Proc Natl Acad Sci U S A (2000) 3.08
Functional analysis of the genes of yeast chromosome V by genetic footprinting. Science (1996) 2.98
Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J Virol (2000) 2.98
Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events. J Virol (1989) 2.90
DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J Virol (1994) 2.89
Different recombinant murine leukemia viruses use different cell surface receptors. Virology (1984) 2.85
DNA microarray analysis of gene expression in response to physiological and genetic changes that affect tryptophan metabolism in Escherichia coli. Proc Natl Acad Sci U S A (2000) 2.83
Large-scale identification of secreted and membrane-associated gene products using DNA microarrays. Nat Genet (2000) 2.79
A 32 degree tail swing in brush border myosin I on ADP release. Nature (1995) 2.73
Statistical methods for linkage analysis of complex traits from high-resolution maps of identity by descent. Genetics (1995) 2.64
Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU. J Virol (1992) 2.61
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol (1999) 2.40
Structure and activities of Escherichia coli DNA gyrase. Cold Spring Harb Symp Quant Biol (1979) 2.35
Phenotypic mixing between N- and B-tropic murine leukemia viruses: infectious particles with dual sensitivity to Fv-1 restriction. Cell (1976) 2.34
Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure. J Virol (1984) 2.32
HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc Natl Acad Sci U S A (1996) 2.30
A topoisomerase from Escherichia coli related to DNA gyrase. Proc Natl Acad Sci U S A (1979) 2.29
Degradation of proteins from the ER of S. cerevisiae requires an intact unfolded protein response pathway. Mol Cell (2000) 2.29
Characterization of three related glucose repressors and genes they regulate in Saccharomyces cerevisiae. Genetics (1998) 2.27
Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A (2000) 2.24
Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol (2001) 2.19
Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue. J Virol (1998) 2.18
Global and specific translational regulation in the genomic response of Saccharomyces cerevisiae to a rapid transfer from a fermentable to a nonfermentable carbon source. Mol Cell Biol (2001) 2.17
Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J Virol (1998) 2.14
Genetic footprinting: a genomic strategy for determining a gene's function given its sequence. Proc Natl Acad Sci U S A (1995) 2.13
A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proc Natl Acad Sci U S A (1994) 2.10
Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc Natl Acad Sci U S A (2001) 2.07
Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res (1999) 2.04
Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection. Virology (1982) 2.02
Loss of Fv-1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle. Cell (1977) 1.95
Translational suppression in retroviral gene expression. Adv Virus Res (1992) 1.93
Visualizing associations between genome sequences and gene expression data using genome-mean expression profiles. Bioinformatics (2001) 1.90
Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule. J Virol (1979) 1.90
Shotgun DNA microarrays and stage-specific gene expression in Plasmodium falciparum malaria. Mol Microbiol (2000) 1.84